Wall Street brokerages forecast that Caretrust REIT Inc (NASDAQ:CTRE) will post $34.73 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Caretrust REIT’s earnings, with estimates ranging from $32.85 million to $36.60 million. Caretrust REIT reported sales of $28.24 million during the same quarter last year, which indicates a positive year-over-year growth rate of 23%. The company is expected to issue its next earnings report on Tuesday, February 6th.

On average, analysts expect that Caretrust REIT will report full-year sales of $34.73 million for the current financial year, with estimates ranging from $127.77 million to $133.00 million. For the next year, analysts expect that the firm will report sales of $147.26 million per share, with estimates ranging from $132.89 million to $161.90 million. Zacks’ sales averages are an average based on a survey of research firms that follow Caretrust REIT.

Caretrust REIT (NASDAQ:CTRE) last issued its quarterly earnings data on Wednesday, November 8th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.01). Caretrust REIT had a net margin of 25.68% and a return on equity of 5.76%. The company had revenue of $32.90 million for the quarter, compared to the consensus estimate of $32.91 million. During the same period in the previous year, the business earned $0.28 EPS. Caretrust REIT’s revenue for the quarter was up 21.4% compared to the same quarter last year.

A number of research firms have commented on CTRE. Stephens set a $19.00 price target on Caretrust REIT and gave the company a “buy” rating in a research note on Friday, January 12th. Zacks Investment Research cut Caretrust REIT from a “hold” rating to a “sell” rating in a research note on Monday. Capital One Financial reiterated an “equal weight” rating and issued a $21.00 price target on shares of Caretrust REIT in a research note on Sunday, October 22nd. Stifel Nicolaus reiterated a “hold” rating and issued a $19.00 price target (up from $17.00) on shares of Caretrust REIT in a research note on Thursday, November 9th. Finally, BidaskClub cut Caretrust REIT from a “hold” rating to a “sell” rating in a research note on Saturday, December 2nd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $19.78.

Several large investors have recently made changes to their positions in the company. Navellier & Associates Inc raised its stake in shares of Caretrust REIT by 1.0% in the second quarter. Navellier & Associates Inc now owns 41,831 shares of the real estate investment trust’s stock worth $776,000 after purchasing an additional 421 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Caretrust REIT by 7.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,277 shares of the real estate investment trust’s stock worth $116,000 after purchasing an additional 437 shares during the last quarter. Pinebridge Investments L.P. raised its stake in shares of Caretrust REIT by 10.7% in the second quarter. Pinebridge Investments L.P. now owns 9,558 shares of the real estate investment trust’s stock worth $177,000 after purchasing an additional 920 shares during the last quarter. Ameritas Investment Partners Inc. raised its stake in shares of Caretrust REIT by 18.2% in the second quarter. Ameritas Investment Partners Inc. now owns 6,329 shares of the real estate investment trust’s stock worth $117,000 after purchasing an additional 975 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its stake in shares of Caretrust REIT by 3.9% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 26,700 shares of the real estate investment trust’s stock worth $495,000 after purchasing an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 91.15% of the company’s stock.

Caretrust REIT (NASDAQ:CTRE) traded up $0.18 during trading on Thursday, reaching $15.60. The company’s stock had a trading volume of 955,900 shares, compared to its average volume of 704,691. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.60 and a current ratio of 1.60. Caretrust REIT has a 52 week low of $14.71 and a 52 week high of $19.86. The stock has a market capitalization of $1,180.00, a PE ratio of 33.91, a PEG ratio of 2.37 and a beta of 0.67.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, January 16th. Stockholders of record on Friday, December 29th were paid a $0.185 dividend. This represents a $0.74 annualized dividend and a dividend yield of 4.74%. The ex-dividend date was Thursday, December 28th. Caretrust REIT’s payout ratio is 160.87%.

COPYRIGHT VIOLATION WARNING: “Caretrust REIT Inc (CTRE) Expected to Announce Quarterly Sales of $34.73 Million” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/01/18/caretrust-reit-inc-ctre-expected-to-announce-quarterly-sales-of-34-73-million.html.

About Caretrust REIT

CareTrust REIT, Inc is a self-administered, self-managed real estate investment trust. The Company is engaged in the ownership, acquisition and leasing of healthcare-related properties. It makes investments in healthcare-related real estate assets. As of December 31, 2016, its real estate portfolio included 154 skilled nursing facilities (SNFs), SNF Campuses, assisted living facilities and independent living facilities.

Get a free copy of the Zacks research report on Caretrust REIT (CTRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Caretrust REIT (NASDAQ:CTRE)

Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.